bearish
MabPharma (迈博医药) IPO: Assembled for a Trade?
796 Views21 Feb 2019 13:45
MabPharma, backed by Chinese private equity investor CDH, is seeking to list in Hong Kong. In this insight, we will discuss the following...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
- Futu Holdings IPO - Given the Team, Execution, and Backers, Might Be Worth a Look at the Low-End27 Feb 2019
- Futu Holdings Pre-IPO - FY18 Updates And Quick Thoughts on Valuation26 Feb 2019
- ECM Weekly (23 February 2019) - Futu, CStone, Dexin, New Century, AB InBev, MabPharma23 Feb 2019
- MabPharma (迈博医药) IPO: Assembled for a Trade?21 Feb 2019
- Shanghai Henlius (复宏汉霖) IPO: Not an Impressive Biosimilar Portfolio30 Jan 2019
- CStone Pharma (基石药业) IPO: Strong Assembly and Backing (Part 1)25 Jan 2019
x